Pharmaceutical

Podcast #5: Doing Digital Deals in Life Sciences | Deal Structure, Terms, and Series Conclusions

Final podcast in Sterling's series, examining how a range of factors influence transaction structure and deal terms.

Jul 24, 2024 - 04:00
Podcast #5: Doing Digital Deals in Life Sciences | Deal Structure, Terms, and Series Conclusions
Final podcast in Sterling's series, examining how a range of factors influence transaction structure and deal terms.
Read the original article

Tags:

Previous Article

Telix raises $398m to advance kidney and brain cancer radiotherapies

Next Article

Agilent agrees to acquire BIOVECTRA for $925m

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Listen: Explaining the E.U.’s pharma overhaul, Lilly’s booming business, & a long-awaited drug approval

Listen: Explaining the E.U.’s pharma overhaul, Lilly’s ...

Apr 27, 2023

STAT+: For-profit biomedical institute, backed by billionaires, launches in Cambridge to speed drug discovery

STAT+: For-profit biomedical institute, backed by billi...

Jan 14, 2024

UTHSC researcher to expedite treatments for PTOA

UTHSC researcher to expedite treatments for PTOA

Aug 22, 2023